DOCSLIB.ORG

The Discovery of Ubiquitin-Dependent Proteolysis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Discovery of Ubiquitin-Dependent Proteolysis The discovery of ubiquitin-dependent proteolysis Keith D. Wilkinson* Department of Biochemistry, Emory University School of Medicine, 4017 Rollins Research Building, 1510 Clifton Road, Atlanta, GA 30322 Edited by Marc W. Kirschner, Harvard Medical School, Boston, MA, and approved August 29, 2005 (received for review June 9, 2005) In early 1980, Irwin A. Rose, Avram Hershko, and Aaron Ciechanover published two papers in PNAS that reported the astounding observation that energy-dependent intracellular proteolysis was far more complicated than the previously accepted models of lyso- somal proteolysis or the action of ATP-dependent proteases such as bacterial lon. In fact, it has turned out to be even more compli- cated than they could have suspected. The general model of covalently attaching a small protein as a targeting signal has proved to be every bit as important to eukaryotic cells as the better understood modifications such as phosphorylation or acetylation. The key player in this modification, a small protein called ubiquitin (APF-1 in these papers), is the founding member of a large family of pro- teins containing the ␤-grasp fold and is used as a posttranslational targeting signal to modify the structure, function, and͞or local- ization of other proteins. The story of this discovery is a textbook example of the confluence of intellectual curiosity, unselfish col- laboration, chance, luck, and preparation. t is a truism in science that the first example of any biological phenom- enon is the hardest to prove. We rely so much on precedent to for- Imulate our hypothesis that something truly unique and novel is often over- looked for many years. The covalent modification of proteins by the attach- ment of other proteins is one such ex- ample (1–6). As we now know, this modification is a targeting mechanism used to move proteins around in the cell. The ubiquitin family of modifiers (ubiquitin, Nedd8, SUMO, ISG15, etc.) has been implicated in the regulation of proteolysis, nuclear localization, chroma- tin structure, genetic integrity, protein quality control, and signaling (6). The prototypical example of this modifica- tion is the covalent attachment of ubiq- uitin to proteins to target them for Fig. 1. The laureates at the Karolinska Institute after their Nobel addresses. Shown are (left to right) degradation by the proteasome and was Aaron Ciechanover, Irwin Rose, and Avram Hershko. first reported in two PNAS papers pub- lished early in 1980 by the 2004 Nobel laureates in chemistry, Avram Hershko, Goldberg’s group showed that damaged transferase and on the rates of bulk pro- Aaron Ciechanover, and Irwin A. Rose or abnormal proteins were rapidly tein turnover in bacteria and mamma- (Fig. 1), and their collaborators (1, 7). cleared from the cell (9–11). He and lian cells. Hershko then established his These two papers outlined the essentials Schimke (11) pointed out that enzymes own laboratory at the Technion-Israel of the system and were amazingly pre- that catalyzed rate-limiting steps in Institute of Technology in Haifa and scient in their interpretations and pre- metabolic pathways were generally continued to collaborate with Tompkins dictions based on simple biochemical short-lived and that their amounts were until his untimely death in 1975. Aaron analysis. responsive to metabolic conditions. Ciechanover (M.D. 1974 and Ph.D. 1981 The authors set out to explain a sim- Thus, by the late 1970s, we began to from Hebrew University-Hadassah Med- ple biological curiosity: the fact that in- suspect that the energy dependence of ical School) completed his military tracellular proteolysis in mammalian intracellular proteolysis reflected some service before joining Hershko as a cells requires energy. Melvin Simpson energy-dependent regulation of proteo- graduate student at the Technion-Israel first showed this in his 1953 studies with lytic systems. Institute of Technology. Irwin A. isotopic labeling of cellular proteins (8), The collaboration of Ciechanover, ‘‘Ernie’’ Rose (Ph.D. in 1952 from the and for the next 25 years there were few Hershko, and Rose was uniquely posi- University of Chicago) did postdoctoral insights into the mechanisms or meta- tioned and qualified to define this regu- studies with Charles Carter at Case bolic logic of this observation. The lation. Avram Hershko (M.D. 1965 and Western Reserve University and Severo hydrolysis of the peptide bond is exer- Ph.D. 1969 from Hebrew University- Ochoa at New York University. He gonic, and there is no thermodynamic Hadassah Medical School) did postdoc- joined the Department of Pharmacology reason to use energy. The apparent re- toral work in the laboratory of Gordon at Yale University in 1954 and moved to quirement for energy could mean only Tompkins at the University of Califor- that there was something we didn’t un- nia at San Francisco where he first be- derstand. Part of the answer began to came interested in protein degradation. *E-mail: [email protected]. become apparent in the mid 1970s when His early studies were on tyrosine amino © 2005 by The National Academy of Sciences of the USA 15280–15282 ͉ PNAS ͉ October 25, 2005 ͉ vol. 102 ͉ no. 43 www.pnas.org͞cgi͞doi͞10.1073͞pnas.0504842102 Downloaded by guest on September 23, 2021 PERSPECTIVE the Institute for Cancer Research at the association of APF-1 with other compo- Fox Chase Cancer Center in 1963. As a nents of the system. mechanistic enzymologist, he gained In the first paper (1), Ciechanover et fame for his studies on proton transfer al. showed that 125I-labeled APF-1 was reactions and the use of isotopic label- promoted to a high molecular weight ing to examine the chemical mechanisms form upon incubation with fraction II used by enzymes. Rose’s interest in pro- and ATP. This association required low tein degradation dated back to the ob- concentrations of ATP and was reversed servations of Simpson, his colleague at upon removal of the ATP. At this time, Yale, who had demonstrated the ATP a postdoctoral fellow in Rose’s labora- dependence of proteolysis in 1953. They tory, Art Haas, began to characterize talked often about this biochemical curi- this association, and he found that the osity, and Rose would come back to this complex survived high pH. To every- question periodically, but made little one’s surprise, the association of 125I- progress. Hershko and Rose first met at labeled APF-1 with proteins in fraction a Fogarty Foundation meeting in 1977 II was covalent! They went on to show where they discovered their mutual in- that the bond was stable to NaOH treat- terests in ATP-dependent proteolysis. ment and that APF-1 was bound to Rose invited Hershko to do a sabbatical many different proteins as judged by in his laboratory at the Institute for SDS͞PAGE. The authors concluded Cancer Research in Philadelphia. This that it was likely that conjugation was began a 10-year collaboration that saw required for proteolysis; the nucleotide Rose hosting the Israeli group every and metal ion requirements were similar summer. Rose was a patron and intellec- for conjugation and proteolysis, as were tual contributor far beyond what might the amounts of ATP and fraction II Fig. 2. Formation of covalent compounds be- be indicated by his authorship on the necessary to maximally stimulate. The tween APF-1 and lysozyme in an ATP-dependent papers of that era. Thus, these two tal- covalent attachment of APF-1 to cellu- reaction. Tracks 1–5, compound formation with 125 ented investigators entered into the col- lar proteins also explained why some I-APF-1; track 1, without ATP; track 2, with ATP; laboration that would define one of the investigators had so much difficulty tracks 3–5, with ATP and 5, 10, or 25 mg of unla- beled lysozyme, respectively; and tracks 6 and 7, several mechanisms of ATP-dependent demonstrating a requirement for APF-1 compound formation with 125I-lysozyme. Condi- protein degradation and frame a new in ATP dependent proteolysis. When tions were as detailed in Methods of ref. 7, except means of viewing cellular regulation. fraction II was prepared from reticulo- that 5 ␮gof125I-lysozyme (40,000 cpm) and 3 ␮gof [See Ciechanover (12) and Goldberg cytes without first depleting the ATP, unlabeled APF-1 were used. Track 6, ATP omitted; (13) for a more complete discussion of most of the APF-1 was initially present track 7, with 2 mM ATP. Contamination in 125I- the various ATP-dependent processes.] in high molecular weight conjugates that labeled lysozyme is indicated. [Reproduced with By 1979, Hershko and Ciechanover were subsequently found in fraction II. permission from ref. 7 (Copyright 1980).] had exploited the seminal observations These conjugates were rapidly disassem- of Etlinger and Goldberg that reticulo- bled by amidases in fraction II, thereby cyte lysates (which lack lysosomes) ex- liberating free APF-1. Thus, there was H2a was covalently modified by the at- hibited ATP-dependent proteolysis of sufficient APF-1 in fraction II to sup- tachment of a small protein called ubiq- denatured proteins (14) and would be port proteolysis. If one first depleted the uitin. Gideon Goldstein first discovered amenable to biochemical fractionation. ATP, APF-1 was liberated before the ubiquitin in his search for thymopoietin Hershko and Ciechanover first showed chromatographic preparation of fraction (17), and he generously shared authentic the system could be separated into two II and APF-1 had to be added back to samples with me. Intrigued by this simi- fractions (I and II) that had to be re- obtain maximal rates of proteolysis. This larity, Urban, Haas, and I went on to combined to generate ATP-dependent series of rather simple experiments con- show that APF-1 was the previously proteolysis (15). Fraction I contained a vincingly demonstrated that APF-1 was known protein called ubiquitin (18).
Load more

Recommended publications
  • Springer A++ Viewer
    PublisherInfo PublisherName : BioMed Central PublisherLocation : London PublisherImprintName : BioMed Central Ubiquitin researchers win Nobel ArticleInfo ArticleID : 5007 ArticleDOI : 10.1186/gb-spotlight-20041007-02 ArticleCitationID : spotlight-20041007-02 ArticleSequenceNumber : 70 ArticleCategory : Research news ArticleFirstPage : 1 ArticleLastPage : 3 RegistrationDate : 2004–10–7 ArticleHistory : OnlineDate : 2004–10–7 ArticleCopyright : BioMed Central Ltd2004 ArticleGrants : ArticleContext : 130595511 Stephen Pincock Email: [email protected] Three researchers who made fundamental breakthroughs in understanding ubiquitin-mediated proteolysis have been awarded the 2004 Nobel Prize in Chemistry, the Royal Swedish Academy of Sciences said on Wednesday (October 6). Aaron Ciechanover and Avram Hershko, from the Israel Institute of Technology, Haifa, and Irwin Rose, of the University of California, Irvine, will share the prize for their discoveries in the 1970s and 1980s that began to reveal the central role of the tiny 76-amino acid protein in numerous cellular processes. "Thanks to the work of the three laureates, it is now possible to understand at a molecular level how the cell controls a number of central processes by breaking down certain proteins and not others," the academy said. "Without doubt they deserve this prize," John Mayer, professor of molecular cell biology at the University of Nottingham, told us. "Protein modification by ubiquitylation is just as important as protein phosphorylation for what goes on in the cell." Ubiquitin-mediated protein degradation governs processes as varied as cell division, DNA repair, quality control of newly produced proteins, and parts of the immune system. Problems with the ubiquitin–proteosome system are implicated in human diseases including cervical cancer and cystic fibrosis. "The reason they've got this Nobel Prize is because ubiquitin is attached to proteins in different ways not only for degradation, but also to make other things happen in the cell," Mayer added.
    [Show full text]
  • Dear Colleague, This Invitation Is Being Sent on Behalf of Prof
    Dear colleague, On behalf of Prof. Fernand Marquis (San Diego State U., USA), Prof. Soteris Kalogirou (Cyprus U. of Technology, Cyprus), and Prof. Bernard Raveau (U. of Caen, France), co-chairs of the 2nd International Symposium on Solid State Chemistry for Applications and Sustainable Development in my capacity as President of SIPS 2020/2021, I am personally inviting you to participate as an author/speaker. This major symposium focuses on solid-state chemistry corresponds to the relationships occurring between the synthesis, structure, and physical-chemical properties of solid inorganic compounds (in most cases), leading to a final compound with optimized properties such as advances in the synthesis routes, design of materials for sustainable energy production, advanced characterization techniques and applications, etc. These and many others are among the topics of the symposium. This symposium will be held as part of the combined SIPS 2020/2021, an annual multidisciplinary summit, organized by the not-for-profit corporation FLOGEN Stars Outreach (www.flogen.org), which is dedicated to achieving sustainability through science and technology applied in various fields. It incorporates summit plenary lectures from well-known speakers that address the link between various domains in the pursuit of sustainable development, as well as specific scientific symposia featuring specialized presentations in a specific domain, with the same goals in mind. The symposium and overall summit are planned to be held in Phuket, Thailand from November 28th – December 2nd 2021. We have confirmed until now the participation of the following 9 Nobel Laureates: Prof. Dan Shechtman, Prof. Didier Queloz, Prof. M. Stanley Whittingham, Sir Konstantin Novoselov, Prof.
    [Show full text]
  • Ubiquitin-Mediated Proteolysis the Nobel Prize in Chemistry for 2004 Is
    Advanced information on the Nobel Prize in Chemistry, 6 October 2004 Information Department, P.O. Box 50005, SE-104 05 Stockholm, Sweden Phone: +46 8 673 95 00, Fax: +46 8 15 56 70, E-mail: [email protected], Website: www.kva.se Ubiquitin-mediated proteolysis The Nobel Prize in Chemistry for 2004 is shared between three scientists who have made fundamental discoveries concerning how cells regulate the breakdown of intracellular proteins with extreme specificity as to target, time and space. Aaron Ciechanover, Avram Hershko and Irwin Rose together discovered ubiquitin- mediated proteolysis, a process where an enzyme system tags unwanted proteins with many molecules of the 76-amino acid residue protein ubiquitin. The tagged proteins are then transported to the proteasome, a large multisubunit protease complex, where they are degraded. Numerous cellular processes regulated by ubiquitin-mediated proteolysis include the cell cycle, DNA repair and transcription, protein quality control and the immune response. Defects in this proteolysis have a causal role in many human diseases, including a variety of cancers. Fig. 1 Ubiquitin-mediated proteolysis and its many biological functions 2 Introduction Eukaryotic cells, from yeast to human, contain some 6000 to 30000 protein-encoding genes and at least as many proteins. While much attention and research had been devoted to how proteins are synthesized, the reverse process, i.e. how proteins are degraded, long received little attention. A pioneer in this field was Schoenheimer, who in 1942 published results from isotope tracer techniques indicating that proteins in animals are continuously synthesized and degraded and therefore are in a dynamic state (Schoenheimer, 1942).
    [Show full text]
  • Los Premios Nobel De Química
    Los premios Nobel de Química MATERIAL RECOPILADO POR: DULCE MARÍA DE ANDRÉS CABRERIZO Los premios Nobel de Química El campo de la Química que más premios ha recibido es el de la Quí- mica Orgánica. Frederick Sanger es el único laurea- do que ganó el premio en dos oca- siones, en 1958 y 1980. Otros dos también ganaron premios Nobel en otros campos: Marie Curie (física en El Premio Nobel de Química es entregado anual- 1903, química en 1911) y Linus Carl mente por la Academia Sueca a científicos que so- bresalen por sus contribuciones en el campo de la Pauling (química en 1954, paz en Física. 1962). Seis mujeres han ganado el Es uno de los cinco premios Nobel establecidos en premio: Marie Curie, Irène Joliot- el testamento de Alfred Nobel, en 1895, y que son dados a todos aquellos individuos que realizan Curie (1935), Dorothy Crowfoot Ho- contribuciones notables en la Química, la Física, la dgkin (1964), Ada Yonath (2009) y Literatura, la Paz y la Fisiología o Medicina. Emmanuelle Charpentier y Jennifer Según el testamento de Nobel, este reconocimien- to es administrado directamente por la Fundación Doudna (2020) Nobel y concedido por un comité conformado por Ha habido ocho años en los que no cinco miembros que son elegidos por la Real Aca- demia Sueca de las Ciencias. se entregó el premio Nobel de Quí- El primer Premio Nobel de Química fue otorgado mica, en algunas ocasiones por de- en 1901 al holandés Jacobus Henricus van't Hoff. clararse desierto y en otras por la Cada destinatario recibe una medalla, un diploma y situación de guerra mundial y el exi- un premio económico que ha variado a lo largo de los años.
    [Show full text]
  • Proteasome Inhibitors in Cancer Therapy: Death by Indigestion
    Cell Death and Differentiation (2005) 12, 1255–1257 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Book Review Proteasome inhibitors in cancer therapy: death by indigestion M Rossi1, A Oberst2, A Emre Sayan1 and P Salomoni*,1 1 MRC, Toxicology Unit, Leicester, UK; 2 IDI-IRCCS Biochemistry Lab, c/o University of Rome Tor Vergata, Rome, Italy * Corresponding author. P Salomoni. E-mail: [email protected] Cell Death and Differentiation (2005) 12, 1255–1257. doi:10.1038/sj.cdd.4401701 Proteasome Inhibitors in Cancer Therapy. Cancer Drug Discovery and Development. By J Adams. Humana Press, Totowa, New Jersey: 2004. pp 312. ISBN: 1-58829-250-9 As Eugene Garfield said, while it is easy to recognize a good same issue containing manuscripts from scientists that have paper, it could be more difficult to recognize a bad paper. In originated in this field.7–10 fact, the results could be weak, but the conclusion could still For those of us engaged in basic research in the field be right, even though not fully supported by the data shown. of cancer and apoptosis, the hope that our work might, in Preliminary reports could also fall in this category. After some small way and at some future juncture, contribute to all, it was not a Cell but a BBRC paper – only a little BBRC of the clinical treatment of human cancers is a major motivator. three impact factor – describing a novel experimental model Proteasome Inhibitors in Cancer Therapy, edited by Julian in which to study ATP-dependent proteolysis.1 In a lysate Adams, which is part of the ‘Cancer Drug Discovery and from rabbit reticulocytes, where the proteolytic activity was not Development’ series from Humana Press, tells the happy tale due to lysosomes (pH optimum of 7.8), they separated two of one drug’s journey from concept, through development, fractions in a DEAE cellulose column, each one individually to FDA approval, and application.
    [Show full text]
  • The Elie Wiesel Foundation for Humanity Nobel
    THE ELIE WIESEL FOUNDATION FOR HUMANITY NOBEL LAUREATES INITIATIVE September 9, 2005 TO: Kansas State Board of Education We, Nobel Laureates, are writing in defense of science. We reject efforts by the proponents of so-called “intelligent design” to politicize scientific inquiry and urge the Kansas State Board of Education to maintain Darwinian evolution as the sole curriculum and science standard in the State of Kansas. The United States has come a long way since John T. Scopes was convicted for teaching the theory of evolution 80 years ago. We are, therefore, troubled that Darwinism was described as “dangerous dogma” at one of your hearings. We are also concerned by the Board’s recommendation of August 8, 2005 to allow standards that include greater criticism of evolution. Logically derived from confirmable evidence, evolution is understood to be the result of an unguided, unplanned process of random variation and natural selection. As the foundation of modern biology, its indispensable role has been further strengthened by the capacity to study DNA. In contrast, intelligent design is fundamentally unscientific; it cannot be tested as scientific theory because its central conclusion is based on belief in the intervention of a supernatural agent. Differences exist between scientific and spiritual world views, but there is no need to blur the distinction between the two. Nor is there need for conflict between the theory of evolution and religious faith. Science and faith are not mutually exclusive. Neither should feel threatened by the other. When it meets in October, 2005, we urge the Kansas State Board of Education to vote against the latest draft of standards, which propose including intelligent design in academic curriculum.
    [Show full text]
  • Steven J. Cohen, Md
    STEVEN J. COHEN, MD Background Oncology Cornell University Director, Rosenfeld Cancer Center and Cancer Service Line Ithaca, NY Chief, Medical Oncology and Hematology Division (BA, Psychology, 1988-1992) Vice-Chair, Department of Medical Oncology Professor of Medical Oncology, Thomas Jefferson University, Stony Brook University School of Medicine Sidney Kimmel Cancer Center Stony Brook, NY (MD, 1992-1996) Steven J. Cohen, MD earned his Bachelor’s degree in Psychology Temple University Hospital in 1992 from Cornell Philadelphia, PA University. In 1996, he earned (Resident, Internal Medicine, 1996-1999) his medical degree from the State University of New York at Fox Chase Cancer Center Stony Brook. Dr. Cohen Temple University Hospital completed his residency in Philadelphia, PA Internal Medicine at Temple (Fellow, Medical Oncology and Hematology, 1999-2001) University Hospital in 1999. He (Chief Fellow, Medical Oncology and Hematology, 2001- completed his fellowship in 2002) Medical Oncology and (Program Director, Hematology/Oncology Fellowship, Hematology in 2002 at Fox 2009-2016) Chase Cancer Center, and also served as Chief Fellow from 2001 to 2002. Fox Chase Cancer Center Philadelphia, PA Dr. Cohen specializes in the care and treatment of GI cancers. He is a member of the American Society of Clinical (Assistant Member, Division of Medical Science, 2002- Oncology, where he has served on the Scientific Program 2004) Committee for Colorectal Cancer and chaired the Test (Attending Physician, Department of Medical Oncology, Development Committee. He is an active member of the GI 2002-2004) Committee of the Eastern Cooperative Oncology Group (Assistant Professor, Divisions of Medical and Population where he has chaired the Colorectal Cancer Subcommittee.
    [Show full text]
  • The Ubiquitin System for Protein Degradation and Some of Its Roles in the Control of the Cell Division Cycle*
    Cell Death and Differentiation (2005) 12, 1191–1197 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Review: Nobel Lecture The ubiquitin system for protein degradation and some of its roles in the control of the cell division cycle* A Hershko*,1 further molecular mechanisms that regulate the expression of specific genes. Owing to the intensive research activity on 1 The B. Rappaport Faculty of Medicine and the Rappaport Institute for protein synthesis, little attention was paid at that time to the Research in the Medical Sciences, Technion-Israel Institute of Technology, fact that many proteins are rapidly degraded to amino acids. Haifa, Israel This dynamic turnover of cellular proteins had been previously * Corresponding author: A Hershko, Unit of Biochemistry, the B. Rappaport known by the pioneering work of Schoenheimer and co- Faculty of Medicine and the Rappaport Institute for Research in the Medical Sciences, Technion-Israel Institute of Technology, 1 Efron Street, P.O. Box workers, who were among the first to introduce the use of 9649, Haifa 31096, Israel. Fax: 9724 853 5773; isotopically labeled compounds to biological studies. They 15 E-mail: [email protected] administered N-labeled L-leucine to adult rats, and the distribution of the isotope in body tissues and in excreta was Received 18.5.05; accepted 18.5.05 examined. It was observed that less than one-third of the Edited by G Melino isotope was excreted in the urine, and most of it was incorporated into tissue proteins.1 Since the weight of the Abstract animals did not change during the experiment, it could be assumed that the mass and composition of body proteins also Owing to the intensive research activity on protein synthesis, did not change.
    [Show full text]
  • Nobel Laureates Meet International Top Talents
    Nobel Laureates Meet International Top Talents Evaluation Report of the Interdisciplinary Lindau Meeting of Nobel Laureates 2005 Council for the Lindau Nobel Laureate Meetings Foundation Lindau Nobelprizewinners Meetings at Lake Constance Nobel Laureates Meet International Top Talents Evaluation Report of the Interdisciplinary Lindau Meeting of Nobel Laureates 2005 Council for the Lindau Nobel Laureate Meetings Foundation Lindau Nobelprizewinners Meetings at Lake Constance I M PR I N T Published by: Council for the Lindau Nobel Laureate Meetings, Ludwigstr. 68, 88131 Lindau, Germany Foundation Lindau Nobelprizewinners Meetings at Lake Constance, Mainau Castle, 78465 Insel Mainau, Germany Idea and Realisation: Thomas Ellerbeck, Member of the Council for the Lindau Nobel Laureate Meetings and of the Board of Foundation Lindau Nobelprizewinners Meetings at Lake Constance, Alter Weg 100, 32760 Detmold, Germany Science&Media, Büro für Wissenschafts- und Technikkommunikation, Betastr. 9a, 85774 Unterföhring, Germany Texts: Professor Dr. Jürgen Uhlenbusch and Dr. Ulrich Stoll Layout and Production: Vasco Kintzel, Loitersdorf 20a, 85617 Assling, Germany Photos: Peter Badge/typos I, Wrangelstr. 8, 10997 Berlin, Germany Printed by: Druckerei Hermann Brägger, Bankgasse 8, 9001 St. Gallen, Switzerland 2 The Interdisciplinary Lindau Meeting of Nobel Laureates 2005 marked a decisive step for the annual Lindau Meeting in becoming a unique and significant international forum for excellence, fostering the vision of its Spiritus Rector, Count Lennart Bernadotte. It brought together, in the heart of Europe, the world’s current and prospective scientific leaders, the minds that shape the future drive for innovation. As a distinct learning experience, the Meeting stimulated personal dialogue on new discoveries, new methodologies and new issues, as well as on cutting-edge research matters.
    [Show full text]
  • Albert Szent-Györgyi (1893 – 1986)
    “Research is to see what everybody else has seen , and to think what nobody else has thought”. Albert Szent-Györgyi (1893 – 1986) Szent-Györgyi 75 – Conference in Szeged The best-known scientific award, the Nobel Prize was honored to Albert Szent- Györgyi 75 years ago, in 1937. Remembering the anniversary, an international conference with the participation of nine Nobel Prize laureates was organized by the University of Szeged, Faculty of Medicine in March 2012. Albert Szent-Györgyi is the only Hungarian Nobel Prize laureate scientist who received this outstanding international prize as an honor for his activity in his homeland. He proceeded with his researches, launched in the Netherlands and Great-Britain, as the head of the Chemistry Department of the University in Szeged (founded in 1921). The subject of his experiments became paprika, from which he soon isolated a multitude of “hexuronic acid”, later known as vitamin C. The Nobel Prize was adjudicated to him "for his discoveries in connection with the biological combustion process with special reference to vitamin C and the catalysis of fumaric acid" by the Medical Faculty of the Royal Caroline Institute in Stockholm in 1937. As commemoration for the illustrious anniversary an imposing international conference was organized by the University of Szeged, Faculty of Medicine between March 22 and 25, 2012. What made this event special is that 9 Nobel Prize laureate scientist visited Szeged: Andrew V. Schally (1977), Bert Sakmann (1991), Robert Huber (1988), Eric Wieschaus (199), Peter C. Doherty (1996), John E. Walker (1997), Tim Hunt (2001), Aaron Ciechanover (2004) és Ada E.
    [Show full text]
  • SHALOM NWODO CHINEDU from Evolution to Revolution
    Covenant University Km. 10 Idiroko Road, Canaan Land, P.M.B 1023, Ota, Ogun State, Nigeria Website: www.covenantuniversity.edu.ng TH INAUGURAL 18 LECTURE From Evolution to Revolution: Biochemical Disruptions and Emerging Pathways for Securing Africa's Future SHALOM NWODO CHINEDU INAUGURAL LECTURE SERIES Vol. 9, No. 1, March, 2019 Covenant University 18th Inaugural Lecture From Evolution to Revolution: Biochemical Disruptions and Emerging Pathways for Securing Africa's Future Shalom Nwodo Chinedu, Ph.D Professor of Biochemistry (Enzymology & Molecular Genetics) Department of Biochemistry Covenant University, Ota Media & Corporate Affairs Covenant University, Km. 10 Idiroko Road, Canaan Land, P.M.B 1023, Ota, Ogun State, Nigeria Tel: +234-8115762473, 08171613173, 07066553463. www.covenantuniversity.edu.ng Covenant University Press, Km. 10 Idiroko Road, Canaan Land, P.M.B 1023, Ota, Ogun State, Nigeria ISSN: 2006-0327 Public Lecture Series. Vol. 9, No.1, March, 2019 Shalom Nwodo Chinedu, Ph.D Professor of Biochemistry (Enzymology & Molecular Genetics) Department of Biochemistry Covenant University, Ota From Evolution To Revolution: Biochemical Disruptions and Emerging Pathways for Securing Africa's Future THE FOUNDATION 1. PROTOCOL The Chancellor and Chairman, Board of Regents of Covenant University, Dr David O. Oyedepo; the Vice-President (Education), Living Faith Church World-Wide (LFCWW), Pastor (Mrs) Faith A. Oyedepo; esteemed members of the Board of Regents; the Vice- Chancellor, Professor AAA. Atayero; the Deputy Vice-Chancellor; the
    [Show full text]
  • Early Work on the Ubiquitin Proteasome System, an Interview with Irwin Rose
    Cell Death and Differentiation (2005) 12, 1162–1166 & 2005 Nature Publishing Group All rights reserved 1350-9047/05 $30.00 www.nature.com/cdd Interview Early work on the ubiquitin proteasome system, an interview with Irwin Rose I Rose*,1 Irwin Rose was one of the first scientists working on UPS mechanisms. In particular, his early work was dedicated to the 1 Department of Physiology and Biophysics, College of Medicine, University of biochemistry and the role of nonlysosomal protein degra- California, Irvine, CA 92697, USA dation. But how did it all begin? What triggered his scientific * Corresponding author: I Rose, Department of Physiology and Biophysics, interest in this field from his previous work? Now a large College of Medicine, University of California, Irvine, CA 92697, USA. family of related proteins exist, with interesting therapeutical E-mail: [email protected] potential. Here, Cell Death and Differentiation asks Irwin Cell Death and Differentiation (2005) 12, 1162–1166. Rose about the early work on enzymology. This interview doi:10.1038/sj.cdd.4401700 was obtained, thanks to the kind help of the Nobel Foundation in Stockholm, http://nobelprize.org (rThe Nobel Founda- tion 2004). CDD: How did you Move from your Early Family Life into your Scientific Interest? We left my birthplace, Brooklyn, New York in 1939 when I was 13. I enjoyed the ethnic variety and the interesting students in my public school, P.S. 134. The kids in my neighborhood were only competitive in games although unfriendly gangs tended to define the limits of our neighborhood. The major extracurricular activities that I can remember were a Victory Garden on school grounds, our contribution to the war effort, and a favorite sport, handball, played between the walls of our apartment house.
    [Show full text]